News Manchester joint venture will trial Morningside's digital he... The University of Manchester has formed a joint venture with Morningside to carry out clinical trials of various digital health technologies developed by the investment group's portfolio co
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
